Peptides Under Fire 2026: The Regulatory Crackdown On GLP-1s And What It Means For Research (Paperback) (ISBN-13: 9798242077195)

The door on compounded GLP-1 peptides slammed shut in 2025. The FDA said manufacturing shortages have ended, grace periods expired, warning letters flooded clinics, shipments seized at ports, and access fragmented overnight.

This is the insider story forums won't tell you. The real timeline, the court battles, the supply chain friction, and what comes next in 2026.

With cheat sheets, myth-busting analysis, and forward predictions, Peptides Under Fire 2026 is the essential guide for researchers, biohackers, and anyone navigating the new reality of peptide access.

Available now